Valleywise Health Initiates PREEVEnT Trial to Enhance Burn Treatment Outcomes

PREEVEnT Trial: A Groundbreaking Approach to Burn Injury Treatment

The Diane and Bruce Halle Arizona Burn Center at Valleywise Health is at the forefront of innovation in burn treatment through its newly launched research study known as the Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) trial. This pivotal study aims to assess whether administering plasma at an early stage can significantly improve survival outcomes for patients suffering from severe burn injuries.

Understanding the PREEVEnT Trial

The PREEVEnT trial is a large-scale clinical study that will involve around 750 participants aged between 18 to 75 years. The focus is primarily on patients with severe thermal burns covering at least 20% of their total body surface area. These patients will be enrolled into the study by emergency medical personnel once they arrive at the burn center, thereby facilitating prompt treatment to address their critical condition.

One of the unique aspects of the PREEVEnT trial is that it operates under Exception from Informed Consent (EFIC). This means that the trial necessitates implementing a potentially life-saving intervention on patients who are too injured to provide consent themselves. While this raises ethical considerations, the design is essential to ensure timely intervention that could be crucial for the patients' survival.

How Plasma Resuscitation Works

The rationale behind utilizing plasma is based on its components, which contain proteins that help maintain blood volume and pressure. This study will evaluate how early plasma administration may contribute to better volume resuscitation and impact the body's response to severe thermal injury. Researchers hope that this approach will not only stabilize patients' conditions but also reduce complications associated with aggressive fluid resuscitation.

Patient Safety and Ethical Measures

Ensuring the safety and rights of participants is paramount. Although the patients may not be able to provide informed consent at the time of treatment, consent for continued participation in the study will be sought once they are able to give it, or from their family members as soon as possible. This ethical framework is designed to protect the dignity of patients while allowing researchers to explore potentially life-saving therapies in critical situations.

Support and Collaboration

The PREEVEnT trial is made possible through a contract award from the Department of Defense (DoD), signifying the importance of this study within the broader context of national health initiatives. The study is expected to provide valuable insights, potentially impacting clinical practices not only in Arizona but also across the United States and beyond.

Valleywise Health’s Commitment to Quality Care

Valleywise Health has a rich history, spanning 148 years, of providing exemplary healthcare in Maricopa County, which is recognized as one of the nation’s fastest-growing areas. The health system encompasses numerous facilities, including a top-tier public teaching hospital, a pioneering burn center, and the largest HIV primary care center in Arizona. The commitment to care without exception ensures that every patient, every time receives the highest standard of medical attention.

For those interested in learning more about the PREEVEnT trial or participating in an anonymous survey regarding this EFIC study, additional information is available at litesnetwork.org/PREEVEnT.

The PREEVEnT trial exemplifies the ongoing evolution in medical research, emphasizing the necessity of timely interventions in critical care scenarios and exploring innovative methods to improve patient outcomes in severe burn cases. As researchers gear up for data collection and analysis, the hope is that this study not only enhances survival rates but ultimately transforms the standard of care for burn victims worldwide.